Chaitanya Iragavarapu

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

University of Kentucky(Current)

University of Cincinnati

Chaitanya Iragavarapu is an author at University of Kentucky specializing in cancer immunology, b-cell malignancy cellular therapy, and immunotherapy.

ORCID

Publications per year

2024–2024

Publications

Interim results from the ELiPSE-1 study: A phase 1, multicenter, open-label study of CNTY-101 in subjects with relapsed or refractory CD19-positive B-cell malignancies.

Krish Patel, Swathi Namburi, Tahir Latif et al. · Journal of Clinical Oncology · 2024 · 12 citations

Medicine, Immunology, Oncology +13

ALPHA3, a Pivotal Phase 2 Study of First-Line Consolidation with Cemacabtagene Ansegedleucel (Cema-Cel) in Patients with Large B-Cell Lymphoma and Minimal Residual Disease after Response to Standard Therapy

Jason R. Westin, Alex F. Herrera, Ryan C. Lynch et al. · Blood · 2024 · 10 citations · Full text

Medicine, Oncology, Cancer Immunology +16

1–2 of 2